JP Morgan Downgrades Sotera Health to Underweight, Announces $17 Price Target
JP Morgan analyst Casey Woodring downgrades Sotera Health (NASDAQ:SHC) from Neutral to Underweight and announces $17 price target.
Stocks · News reference
Progress on Commercial-Scale Cobalt-60 Production Initiative
Sotera Health subsidiary Nordion continues its multi-year collaboration with Westinghouse and PSEG to establish the first commercial-scale cobalt-60 production platform in the United States.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- fiscal.ai
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Transcript: Sotera Health Q2 2026 Earnings Conference Call
Sotera Health (NASDAQ:SHC) held its second-quarter earnings conference call on Thursday. Below is the complete transcript from the call. Benzinga APIs provide real-time access to earnings call transcripts and financial
8-K filing — Sotera Health Co (SHC)
Filed: 2026-08-14 AccNo: 0001822479-26-000050 Size: 141 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers